Clinical Trial Update: Comparing the Efficacy of the ConvaTec Engenex® Negative Pressure Wound Therapy Device to Moist Wound Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the ConvaTec Engenex negative pressure wound therapy device to moist wound therapy for diabetic foot wounds has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• Engenex Negative Pressure Wound Therapy Device

Snippet

Sponsor: Georgetown University | Conditions: Diabetes, Foot Wound | Phase 4 | Status: WITHDRAWN